Pharmacokinetics in special populations

Author： Poggesi Italo Benedetti Margherita Strolin Whomsley Rhys Lamer Sophie Le Molimard Mathieu Watelet Jean-Baptiste

ISSN： 0360-2532

Source： Drug Metabolism Reviews, Vol.41, Iss.3, 2009-08, pp. : 422-454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Migraine management in special populations

Inpharma, Vol. 1, Iss. 1438, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Introduction to Special Issue “Addiction Pharmacotherapy and Special Populations”

By McCance-Katz Elinore

Substance Use & Misuse, Vol. 40, Iss. 13-14, 2005-12 ,pp. : 1895-1897

Informa Healthcare

Access to resources Recommend Favorite

Editorial: Antiplatelet and Anticoagulation Treatment in Special Populations

Current Pharmaceutical Design, Vol. 23, Iss. 9, 2017-04 ,pp. : 1273-1274

Bentham Science Publishers

Access to resources Recommend Favorite

Possible Interethnic Differences in Omeprazole Pharmacokinetics: Comparison of Jordanian Arabs with Other Populations

By Shilbayeh Sireen Tutunji Maha F.

Clinical Pharmacokinetics, Vol. 45, Iss. 6, 2006-01 ,pp. : 593-610

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Meloxicam in East Asian Populations: The Role of Ethnicity on Drug Response

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 6, Iss. 12, 2017-12 ,pp. : 823-832

John Wiley & Sons Inc

Access to resources Recommend Favorite